Pierre Potier

This inventor holds 33 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Agence Nationale De Valorisation De La Recherche (Anvar), Rhone-Poulenc Sante. Active years: 1976-2016.

USPTO Granted Patents = 33 (Patent Applications = 2)

% Patents Active = 90.9

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 687(Granted Patents)

Location History:

Bois-D'ardy, FR (1982)
Gif S/ Yvette, FR (1988)
Bois-Darcy, FR (1976 - 1989)
Paris, FR (1989 - 2016)

Company Filing History:

11 out of 5,383

Centre National De La Recherche Scientifique

patents

5 out of 338

Agence Nationale De Valorisation De La Recherche (Anvar)

Agence Nationale De Valorisation De La Recherche

Hoechst Aktiengesellschaft

Societe De Conseils De Recherches Et D'applications Scientifiques

Years Active: 1976-2016

Loading Chart...

Areas of Expertise:

Age Inhibitors

Galanthamine Derivatives

Pharmaceutical Compositions

Depigmenting Compositions

Indole Compounds

Taxol Derivatives

Vincamine Derivatives

Bicyclic Aminocarboxylic Acids

Phenylpyrrolic Compounds

Guanidine Structure Compounds

Seco Bis-Indolic Compounds

Vasodilating Compounds

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9512176 - Age inhibitors (2016-12-06),

2. RE41366 - Total synthesis of galanthamine, analogues and derivatives thereof (2010-05-31),

3. 7432087 - Method for preparing (2S, 3R, 4S)-4-hydroxyisoleucine and analogues thereof (2008-10-07),

4. 7109327 - Total synthesis of galanthamine, analogues and derivatives thereof (2006-09-19),

5. 6544533 - 10-hydroxy-2-decenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging (2003-04-08),

6. 5958903 - Galanthamine derivatives, and their pharmaceutical compositions (1999-09-28),

7. 5925797 - .beta.-methylene aldehydes and preparation of compounds of interest by (1999-07-20),

8. 5719187 - Compounds having a guanidine structure and pharmaceutical composition (1998-02-17),

9. 5622957 - Benzopyrrolizinoquinolizinones (1997-04-22),

10. 5602131 - EburnanE analogues (1997-02-11),

11. 5484793 - Compounds derived from 6-azaindoles as ligands of the benzodiazepine (1996-01-16),

12. 5481010 - 7-deacetoxy beccatine IV derivative and preparation and use thereof (1996-01-02),

13. 5480884 - Compounds having a guanidine structure (1996-01-02),

14. 5445816 - Depigmenting cosmetic and/or dermatological composition containing a di- (1995-08-29),

15. 5395624 - Depigmenting cosmetic and/or dermatological composition containing a di- (1995-03-07),

Title: Inventor Pierre Potier - Pioneer in Chemistry Innovations

Introduction: Pierre Potier, a renowned male inventor hailing from Paris, France, made significant contributions to the field of chemistry through his groundbreaking innovations and inventions.

Latest Patents: Pierre Potier's latest patents focus on novel pharmaceutical compounds with potential applications in treating various diseases, showcasing his ongoing commitment to advancing medical science.

Career Highlights: Throughout his illustrious career, Pierre Potier has been recognized for his pioneering work in organic chemistry, particularly in the synthesis of complex molecules. His research has led to the development of life-saving drugs and innovative chemical processes.

Collaborations: Pierre Potier has collaborated with leading pharmaceutical companies, research institutions, and universities worldwide to further his research and bring his inventions to the market. His collaborative efforts have resulted in transformative advancements in the field of chemistry.

Conclusion: Pierre Potier's legacy as an inventor and chemist continues to inspire future generations of innovators, with his contributions leaving an indelible mark on the world of science and medicine.